跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,767 条关于
“HRS-1596”
全部
3,767
临床试验
2,738
药物
647
机构
23
资讯
359
4天前
Hengrui Medicine Gains Clinical Trial Approval for Ten New Drugs, Including Weight Loss
11个月前
HengRui Advances KRAS G12D Inhibitor HRS-4642 to Phase 3 Trial in Pancreatic Cancer
去年
Hengrui Licenses Heart Disease Drug HRS-1893 to Braveheart Bio for $65M Upfront, Potential $1B+ Total
去年
Merck Licenses Oral Lipoprotein(a) Inhibitor HRS-5346 from Hengrui Pharma in $1.97 Billion Deal
11个月前
Mallinckrodt to Present New Terlipressin Data at Kidney Week 2025 for Hepatorenal Syndrome Treatment
去年
Mallinckrodt to Present Five Clinical Studies on TERLIVAZ for Hepatorenal Syndrome at DDW 2025
6个月前
Hengrui Pharma and Braveheart Bio Report Promising Phase 2 Results for Next-Generation Cardiac Myosin Inhibitor in Obstructive Hypertrophic Cardiomyopathy
去年
GSK Secures $12.5 Billion Deal with Hengrui for COPD Drug and 11 Additional Programs
去年
FDA Grants Compassionate Use Approval for Novel Reverse Hip Replacement System in Spinal Fusion Patient
2年前
Investors Launch $400M Hercules Startup to Develop Novel GLP-1 Therapies for Obesity and Diabetes
第 1 页,共 36 页
上一页
下一页